RS

Rajendiran Sellamuthu

Active Director Director DIN 10132216
DIN 10132216 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Rajendiran Sellamuthu

Data last updated:

Rajendiran Sellamuthu is a Director at Dieto Health Private Limited (since 2023). Dieto Health Private Limited reported revenue of ₹4,490 (FY 2025).

DIN 10132216
Primary Designation Director
First Appointment 25 Apr 2023
Oldest Company Age 3 yrs
Largest company Dieto Health Private Limited · ₹4,490 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dieto Health Private Limited U86909TZ2023PTC028227
Director25 Apr 20232023₹4,490 (FY 2025)Active

Board colleagues of Rajendiran Sellamuthu

NameDINCompanyDesignation
Sarojini Sellamuthu11196358Dieto Health Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Dieto Health Private Limited
Premium access

Shareholding and investment profile for Rajendiran Sellamuthu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendiran Sellamuthu

Rajendiran Sellamuthu currently holds 1 directorship: Dieto Health Private Limited (Director, since 25 Apr 2023, revenue ₹4,490 (FY 2025)).

Rajendiran Sellamuthu was first appointed on 25 Apr 2023 as Director at Dieto Health Private Limited.

The current boards of Rajendiran Sellamuthu's companies include Sarojini Sellamuthu (Dieto Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available